Abstract:I read with great interest the article by Das et al. Although presence of nonalcoholic fatty liver (NAFL) in nonobese individuals is a fairly common observation in India, this is the first such scientific documentation for the same. However, I would like to make a few points in this regard. First, NAFL constitutes a wide spectrum of liver disease with varied natural history extending from simple steatosis to more sinister variants, i.e., nonalcoholic steatohepatitis (NASH) and fibrosis/cirrhosis. Only a proportion of NAFL actually progresses to the more sinister end of this spectrum. Therefore, instead of a blanket focus on NAFL, it would be more appropriate to identify the subset of patients with NAFL who are more likely to progress to NASH. In this regard, the authors have defined ‘‘potentially significant NAFL’’ as ‘‘subjects with definite NAFL who had persistently elevated ALT (>40 IU/L)’’. However, even in this study only one-third of these subjects with ‘‘potentially significant NAFL’’ were found to have NASH on liver biopsy, which means elevated ALT alone is not a good enough marker of ‘‘potentially significant’’ NAFL. A full panel of noninvasive markers of liver fibrosis would be more appropriate to define this subset and save costly and/or potentially harmful procedures like liver biopsy or computed tomography scans for them. Second, although the authors have claimed to have excluded people with alcohol consumption from this study, this population in context comes largely from a tribal background who indulges in many nonconventional forms of ethanol consumption, e.g., mahua flower (Madhuca longifolia). It would be interesting to know if the authors have ruled out those possibilities as well. Third, risk of NAFL is undoubtedly associated with obesity and metabolic syndrome and has been traditionally associated with more affluent living standards. In the current study too, even nonobese subjects with NAFL had worse metabolic parameters and higher income than their age-matched and sex-matched counterparts who did not have NAFL. Nevertheless, coexistence of intrauterine and neonatal malnutrition and the development of obesity, type 2 diabetes, and related comorbidities have been confirmed in a number of studies in humans and animal models. Moreover, it has been shown that, in humans, the intrahepatic lipid content increase following starvation also may be due to reduced apolipoprotein B-100 production and hepatic lipid export, and/or impaired mitochondrial function; this could have implications for exacerbations of steatohepatitis that is sometimes seen with rapid weight loss, anorexia nervosa, and parenteral nutrition. Therefore, in contrast to the popular view, malnutrition rather than obesity at different stages of life may well be an explanation for pathogenesis of NAFL in this predominantly poor population.

Is non-alcoholic fatty liver disease the risk factor for the occurrence of primary bronchogenic carcinoma

Causal Association of Nonalcoholic Fatty Liver Disease with 22 Extrahepatic Cancers: A Mendelian Randomization Study.

Incidence of metabolic syndrome and non-alcoholic fatty liver diseases in patients with different histological types of lung cancer

Relationship Between Colorectal Adenomatous Polyps and Non-alcoholic Fatty Liver Disease in A Physical Check-up Population

[The Association Between Body Mass Index and Non-Alcoholic Fatty Liver Disease].

Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China

Relationship Between Non-Alcoholic Fatty Liver Disease and the Perioperative and Short-Term Prognosis of Breast Cancer

Association Between Non-Alcoholic Fatty Liver Disease and the Risk of Pulmonary Nodules in Patients with Intestinal Polyps

Association of nonalcoholic fatty liver disease and liver cancer

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis

Is Cigarette Smoking an Independent Risk Factor or a Cofactor for Nonalcoholic Fatty Liver Disease?

NAFLD Leads to Liver Cancer: Do We Have Sufficient Evidence?

High Prevalence of Colorectal Neoplasm in Patients with Non-Alcoholic Steatohepatitis

Active Smoking, Passive Smoking, and Risk of Nonalcoholic Fatty Liver Disease (NAFLD): a Population-Based Study in China.

Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus

Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis

Risk factors of early liver metastasis in patients with breast cancer.

The Relationship Between Fatty Liver Disease and Liver Metastases from Colorectal Cancer

Associations Between Metabolic Dysfunction-Associated Fatty Liver Disease and Extrahepatic Cancers: a Cohort in China

Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey

Non-alcoholic fatty liver disease increases the risk of biochemical recurrence in high-grade metastatic prostate cancer patients